Left Menu
Development News Edition

UPDATE 1-European shares unchanged amid doubts over COVID-19 vaccine

Reuters | Updated: 20-05-2020 14:28 IST | Created: 20-05-2020 14:28 IST
UPDATE 1-European shares unchanged amid doubts over COVID-19 vaccine

European shares were flat on Wednesday after a downbeat session on Wall Street, as doubts over a potential COVID-19 vaccine fanned concerns about whether and how fast the world can successfully emerge from the coronavirus crisis.

Still, a boost from healthcare stocks helped the pan-European STOXX 600 shed early losses, and the index was last trading flat. Wall Street fell more than 1% overnight after a media report questioned the validity of the results of U.S. drugmaker Moderna's coronavirus vaccine trial that had sent stocks soaring on Monday.

A market recovery from March lows has stalled in May, as investors weigh the chance of a resurgence in coronavirus cases as many countries restart their economies after months-long lockdowns. The STOXX 600 is down 0.5% this month after a 6% jump in April. "Investors are playing a waiting game," said Edmund Shing, global head of equity derivatives strategy at BNP Paribas. "The reason for that is we want to see how the exit from lockdowns proceed and see how quickly each economy picks up."

European markets have cheered a Franco-German proposal this week for a 500 billion-euro Recovery Fund that would bind all 27 European Union states to raise debt jointly to offer grants to regions hit hardest by the coronavirus pandemic. However, Austrian Chancellor Sebastian Kurz said on Tuesday a group of EU states will propose funding the recovery efforts with loans, not grants.

A series of positive corporate updates limited losses in the markets. Shares of British retailer Marks & Spencer jumped 4.0% after saying that it would accelerate its latest turnaround programme as it dealt with the fallout from the coronavirus crisis and reported a 21% fall in annual profit.

The world's biggest credit data company Experian Plc gained 6.4% as it said its executive directors would take a 25% salary cut for six months, but forecast first-quarter organic revenue to decline by just 5% to 10%. AstraZeneca Plc rose 1.3% after the U.S. Food and Drug Administration approved Merck Inc's and its Lynparza as a treatment for a form of prostate cancer.

French food group Danone rose 0.8% after it confirmed it would pay out a 2019 dividend and that no share buyback operations would take place this year. Swedish video game group Embracer tumbled 9.6% after weak quarterly report.



Why COVID-19 is unstoppable in USA despite it being ranked at the top of GHS Index?

Several worst-hit countries such as Italy, France, Spain, the UK, Canada, and Russia have peaked COVID-19 cases in April. Almost all of them have gradually flattened the curve. However, the USA is setting new daily records of infections tha...

COVID-19 seems cooking biggest ever global scam

The increasing number of corruption cases on COVID-19 funds from throughout the world and involvement of high profile persons indicate that the countries cant ignore corruption in their pandemic response programs. This has generated the nee...

Health Management Information Systems lack holistic, integrated, and pandemic resilient character

Being a part of the United Nations system, the World Health Organization WHO deserves its share of rebuke for its alleged failure issue COVID-19 health emergency alerts on appropriate time. However, the pandemic has also exposed loopholes i...

Pride in the time of coronavirus: a welcome move online?

This year is different in many ways not least as celebrations are also taking place against the dramatic backdrop of a global health crisis and a resurgence in grassroots activism following the death of George Floyd in Minneapolis. ...


Latest News

BJP committed to reservation: Nityanand Rai

Union Minister for State for Home Nityanand Rai on Monday said that BJP is committed to reservation for weaker sections and the party-led government was working for the welfare of all citizens. The BJP is committed to the reservation and no...

Biocon highlights details of its drug Itolizumab approved as life-saving COVID-19 medicine

Bengaluru based biotech major Biocon on Monday announced that its drug Itolizumab, which will hit the market as ALZUMAb, has received permission from the Drugs Controller General of India for use in moderate to severe COVID-19 patients. It ...

Bahrain top court upholds death sentences against two activists

Bahrains highest court upheld death sentences against two activists for bombing a convoy and killing a police officer after convictions that human rights groups say were based on confessions extracted through torture. Mohammed Ramadhan and ...

SC refuses to entertain plea for restrictions on Amarnath Yatra due to COVID

The Supreme Court on Monday refused to entertain a plea seeking restrictions on devotees in the Amarnath Yatra pilgrimage this year due to COVID-19 pandemic, saying the issue has to be left with the local administration to look into. We hav...

Give Feedback